AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

INTERNATIONAL BIOTECHNOLOGY TST PLC

Report Publication Announcement Jun 6, 2024

5163_rns_2024-06-06_cef6a12b-59bc-482e-9c09-a9cc410a3b7d.html

Report Publication Announcement

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 4536R

Intl. Biotechnology Trust PLC

06 June 2024

INTERNATIONAL BIOTECHNOLOGY TRUST PLC ("IBT")

Latest Factsheet and Blog

IBT's factsheet for the month ended 30 April 2024 is now available directly via its web page. Please click here , then 'latest factsheet'.

IBT recently celebrated its 30-year anniversary, having launched as a pioneering investment trust dedicated to the nascent opportunity in biotech back in 1994. In the latest blog post, Marking IBT's 30-year anniversary with a look at the transformation of cancer therapy, Fund Managers Ailsa Craig and Marek Poszepczynski explore the key developments in cancer treatment during this time and the outlook for future breakthroughs, which are collectively profoundly changing the prospects for many patients.

The blog can be read here: https://www.schroders.com/en-gb/uk/individual/content/marking-ibt-s-30-year-anniversary-with-a-look-at-the-transformation-of-cancer-therapy/

To sign up for IBT updates by email, please click here .

ENDS

Enquiries:

Schroder Investment Management Limited

Augustine Chipungu (Press)

Kirsty Preston

Kerry Higgins (Company Secretary)
020 7658 6000

020 7658 6000
Kaso Legg Communications (Financial PR)

Charles Gorman                       

Henry Taylor

Effie Aye Maung Hider
[email protected]

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NRAFQLFBZQLXBBD

Talk to a Data Expert

Have a question? We'll get back to you promptly.